Paraish S. Misra, M.D.
@paraishm
Nephrologist interested in Diabetes, Stem Cells, Transplantation, and Bioinformatics. Always learning.
ID: 1246102263862562816
03-04-2020 15:48:33
175 Tweet
139 Followers
185 Following
Not too much, not too little—just the right amount: the story of YAP in the #podocyte doi.org/10.1016/j.kint… Original article: doi.org/10.1016/j.kint… Caitríona McEvoy Darren Yuen Department of Medicine University of Toronto Trinity College Dublin Unity Health Toronto Trinity Kidneys #KICommentary #podocytes #diabeticpodocyteinjury
Thrilled to celebrate this achievement with Cristina Nostro and the Nostro Lab! Grateful for all the support from my family, friends, supervisors, and peers and looking forward to the next chapter. Onward and Upward! #UofTGrad24
Our first ASON American Society of Onconephrology Position Statement Committee publication. Many thanks to all our multidisciplinary collaborators and co-chair Sandra Herrmann MD, FASN Part 2:
How to harness vascular and immune cells to improve survival and function of islets and sc-islets in vitro and in vivo. A review with Adriana Migliorini #COGEDE edited by Anne Grapin-Botton & Jonathan Loh 🙌 authors.elsevier.com/sd/article/S09…
Full article: Human research islet cell culture outcomes at the Alberta Diabetes Institute IsletCore James Lyon Alice Carr tandfonline.com/doi/full/10.10…
Automated insulin delivery has been a huge step forward, but people would prefer not to have T1D and sensors and infusion sets can let them down. We need to keep pressing forward Alberta Diabetes. Great to collaborate with Shareen Forbes Sufyan Hussain Katarina Braune, MD
Francis Lynn and team present a new INS2A-EGFP/+;IAPP2A-mScarlet/+ hESC line providing a useful tool for tracking populations of maturing glucose-responsive hESC-derived β cells in vitro #stemcells #islets #diabetes sciencedirect.com/science/articl…
Itai Yanai How about forcing scientists to read the work and evaluate themselves, rather than letting 3 random reviewers selected by an over-worked (often young and inexperienced) journal editor decide. We should be able to make the effort for recruitment, promotion, awards
Here you can find our latest review on cellular therapies for T1D rdcu.be/dSQlT Thanks to Grattoni lab, Nicholas Mamrak & Jaime Giraldo Breakthrough T1D, Mark Poznansky Vaccine & Immunotherapy Center MGH and Paul de Vos Research UMCG for leading this effort. Enjoy reading
Kidney transplant in the Myeloma patient is increasingly feasible but comprises pros and cons American Society of Onconephrology Memorial Sloan Kettering Cancer Center